Category: Blog

Blitzumfrage Private Equity : Reaktionen auf SARS-CoV-2 Private Equity als Impfstoff gegen ökonomische Kriseninfektion? Vorwort Der Corona-Virus Covid19 oder SARS-CoV-2,

After reviewing the impact of COVID on currently ongoing post-merger integration projects in our first article of this series, let’s have a

This is the first article of a series on the impact of COVID-19 on M&A, and we start with post